| Date Filed | Type | Description |
| 06/28/2023 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Sold 16 shares
@ $12.93, valued at
$206.9 |
|
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/14/2023 |
SC 13G/A
| Chione Ltd reports a 3.9% stake in Karyopharm Therapeutics Inc. |
| 11/28/2022 |
SC 13G
| Chione Ltd reports a 18.5% stake in Acrivon Therapeutics, Inc. |
| 11/21/2022 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Bought 400,000 shares
@ $12.5, valued at
$5M
Converted 3,445,940 shares
@ $0
Converted 10,657 shares
@ $0
Converted 8,497,692 preferred shares
@ $0
Converted 26,281 preferred shares
@ $0 |
|
| 11/14/2022 |
3/A
| Chione Ltd (10% Owner) has filed a Form 3/A on Acrivon Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/26/2021 |
SC 13D
| Chione Ltd reports a 6.8% stake in Sera Prognostics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/04/2019 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 149,624 shares
@ $4.1378, valued at
$619.1k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/07/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 160,000 shares
@ $21.0641, valued at
$3.4M
Sold 4,800 shares
@ $20.5154, valued at
$98.5k
|
|
| 09/04/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 200,000 shares
@ $20.9995, valued at
$4.2M
Sold 11,468 shares
@ $21.0495, valued at
$241.4k
Sold 40,000 shares
@ $20.6018, valued at
$824.1k
|
|
| 08/29/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 14,026 shares
@ $18.521, valued at
$259.8k
Sold 200,000 shares
@ $19.5914, valued at
$3.9M
|
|
| 08/14/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 702 shares
@ $18.5, valued at
$13k
|
|
| 08/09/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 10,602 shares
@ $18.6, valued at
$197.2k
Sold 2,800 shares
@ $18.6066, valued at
$52.1k
Sold 67,474 shares
@ $18.5076, valued at
$1.2M
|
|
| 07/25/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 20,000 shares
@ $18.6611, valued at
$373.2k
Sold 9,144 shares
@ $18.6288, valued at
$170.3k
Sold 895 shares
@ $18.5151, valued at
$16.6k
|
|
| 07/23/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 100,000 shares
@ $18.8994, valued at
$1.9M
Sold 26,742 shares
@ $19.2134, valued at
$513.8k
|
|
| 07/18/2018 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 2,654 shares
@ $18.5233, valued at
$49.2k
Sold 17,346 shares
@ $18.5, valued at
$320.9k
Sold 30,000 shares
@ $18.5335, valued at
$556k
|
|
| 02/13/2018 |
SC 13G/A
| Chione Ltd reports a 18.1% stake in Karyopharm Therapeutics Inc. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/27/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 18,824 shares
@ $8.0261, valued at
$151.1k
|
|
| 06/15/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 7,074 shares
@ $8.512, valued at
$60.2k
|
|
| 06/10/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 15,541 shares
@ $9.3421, valued at
$145.2k
Sold 30,000 shares
@ $9.1366, valued at
$274.1k
|
|
| 06/08/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 20,000 shares
@ $9.2232, valued at
$184.5k
Sold 20,000 shares
@ $9.2543, valued at
$185.1k
|
|
| 06/06/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 17,855 shares
@ $9.6468, valued at
$172.2k
|
|
| 06/01/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 40,000 shares
@ $9.58, valued at
$383.2k
Sold 17,096 shares
@ $9.6556, valued at
$165.1k
Sold 17,568 shares
@ $9.6384, valued at
$169.3k
|
|
| 05/27/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 27,940 shares
@ $9.8261, valued at
$274.5k
Sold 18,182 shares
@ $9.5857, valued at
$174.3k
|
|
| 05/23/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 20,000 shares
@ $8.1822, valued at
$163.6k
Sold 40,000 shares
@ $8.5187, valued at
$340.7k
Sold 33,932 shares
@ $8.765, valued at
$297.4k
|
|
| 05/19/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 33,800 shares
@ $8.1503, valued at
$275.5k
Sold 30,000 shares
@ $8.1496, valued at
$244.5k
|
|
| 05/17/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 400 shares
@ $8.0087, valued at
$3.2k
Sold 10,000 shares
@ $8.0065, valued at
$80.1k
|
|
| 05/12/2016 |
4
| Chione Ltd (10% Owner) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 20,000 shares
@ $8.1394, valued at
$162.8k
Sold 11,868 shares
@ $8.4142, valued at
$99.9k
|
|
|